On its own, the potential of IMV Inc.’s (IMV Stock Quote, Chart TSX:IMV) cancer-fighting drug DPX-... Read More
Biotech company IMV (Quote, Chart TSX:IMV) has reported positive preliminary results from its trial ... Read More
A new development at IMV (Quote, Chart TSX:IMV) has Mackie Research Capital analyst André Uddin mai... Read More
Immune therapy vaccine developer IMV (TSX, NASDAQ:IMV) just released its second quarter financials, ... Read More
Douglas Loe of Echelon Wealth Partners feels that data from immune therapy developer IMV’s (TSX, N... Read More
While still in the early stages of clinical testing of its cancer vaccine DPX-Survivac, IMV Inc.’s... Read More
Biotech firm Immunovaccine Technologies (Immunovaccine Stock Quote, Chart, News: TSX:IMV) has announ... Read More
Ahead of preclinical data it will present at the American Association for Cancer Research (AACR) mee... Read More
The stock has already come a long way over the past six months, but analyst Doug Loe of Echelon Weal... Read More
The stock is up more than 140 per cent year to date, but Mackie Research Capital analyst Andre Uddin... Read More
Mackie Research Capital analyst Andre Uddin says Immunovaccine Inc.’s (Immunovaccine Inc. Stoc... Read More
A quarter that was about in-line with his expectations has Mackie Research Capital analyst André Ud... Read More
The news from Liberia, Sierra Leone, Guinea, Nigeria and now Senegal is not good. The World Health O... Read More
Recent news that Halifax-based Immunovaccine (TSXV:IMV) was pulling its proposed public financing du... Read More
It’s been nearly a century since Canada’s greatest achievement in biotech took place; th... Read More
Share
Tweet
pin
Share